EUROBIO-SCIENTIFIC (ALERS.PA) Stock Income Statement
EPA:ALERS - Euronext Paris - Matif - FR0013240934 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 154.56M | 130.00M | 152.61M | 184.71M | 188.86M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 82.71M | 68.76M | 81.66M | 82.48M | 78.45M | |||
| Gross Profit | 71.85M | 61.24M | 70.95M | 102.23M | 110.41M | |||
| Operating Expenses | 58.24M | 46.70M | 40.08M | 32.12M | 29.20M | |||
| Research and Development | 4.64M | 5.91M | 3.47M | 3.44M | 2.23M | |||
| Selling, General, and Administrative Expenses | 45.46M | 33.52M | 31.00M | 24.50M | 22.50M | |||
| Operating Income | 13.62M | 14.54M | 30.87M | 70.12M | 81.21M | |||
| Interest Income/Expense | -7.04M | -3.61M | -598.00K | -970.00K | -793.00K | |||
| Other Income/Expense | 1.36M | 1.89M | 81.00K | 1.09M | 443.00K | |||
| Non Recurring Items | -1.48M | -5.84M | -604.00K | 1.07M | 30.00K | |||
| Income Before Taxes | 6.28M | 6.98M | 29.68M | 71.31M | 80.89M | |||
| Income Tax | 2.29M | 2.14M | 4.75M | 10.77M | 7.41M | |||
| Net Income | 4.00M | 4.83M | 24.94M | 60.54M | 73.48M | |||
| EBITDA | 30.67M | 28.79M | 40.09M | 77.06M | 88.48M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.39 | 0.43 | 2.43 | 5.57 | 6.53 | |||
| Statistics | ||||||||
| Gross Profit Margin | 46.49% | 47.11% | 46.49% | 55.35% | 58.46% | |||
| Profit Margin | 2.59% | 3.72% | 16.34% | 32.78% | 38.91% | |||
| Operating Profit Margin | 8.81% | 11.18% | 20.23% | 37.96% | 43.00% | |||
All data in EUR